Completed PHASE4 INTERVENTIONAL 2-arm NCT00320281

Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.

Botulinum Toxin A for the Treatment of Cervical/Shoulder Pain Following Acute Spinal Cord Injury.

Sponsor: Allergan

Updated 10 times since 2017 Last updated: Sep 22, 2020 Started: Apr 30, 2006 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Pain and Spinal Cord Injury, this trial is completed. The trial is conducted by Allergan and has accumulated 10 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Dec 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Nov 2020 — Jan 2021 [monthly]

Completed PHASE4
Oct 2020 — Nov 2020 [monthly]

Completed PHASE4
Jun 2018 — Oct 2020 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Allergan
Craig Hospital
The Craig H. Neilsen Foundation

Data source: Craig Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Englewood, United States